Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice - Wikidata - awgldk - TriplyDB

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

http://www.wikidata.org/entity/Q35083721

about

Evolutionary origins of insulin resistance: a behavioral switch hypothesis The pancreatic stellate cell: a star on the rise in pancreatic diseases Immune-compromised state in the rat pancreas after chronic alcohol exposure: the role of peroxisome proliferator-activated receptor gamma Complex role for the immune system in initiation and progression of pancreatic cancer.The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitis Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol/high fat diet induced pancreatitis Pharmacological attenuation of chronic alcoholic pancreatitis induced hypersensitivity in rats.Topical Administration of Acylated Homoserine Lactone Improves Epithelialization of Cutaneous Wounds in Hyperglycaemic Rats.Fibrogenesis in the pancreas after acinar cell injury.Mechanisms of disease: chronic inflammation and cancer in the pancreas--a potential role for pancreatic stellate cells?Pancreatic stellate cells: new target in the treatment of chronic pancreatitis.PPARs Mediate Lipid Signaling in Inflammation and Cancer.Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis Peroxisome proliferator-activated receptor-γ agonist troglitazone suppresses transforming growth factor-β1 signalling through miR-92b upregulation-inhibited Axl expression in human keloid fibroblasts in vitro.Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis.Signal transduction in pancreatic stellate cells.Pathogenesis of pancreatic cancer: lessons from animal models.Pancreatic stellate cell: Pandora's box for pancreatic disease biology.P2X7 Receptor Mediates Spinal Microglia Activation of Visceral Hyperalgesia in a Rat Model of Chronic Pancreatitis.Chronic pancreatitis: potential future interventions.The Role of Plant-derived Products in Pancreatitis: Experimental and Clinical Evidence.Protection against chronic pancreatitis and pancreatic fibrosis in mice overexpressing pancreatic secretory trypsin inhibitor.Prostaglandin E2 modulates TNF-alpha-induced MCP-1 synthesis in pancreatic acinar cells in a PKA-dependent manner.Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis.Endothelial cell peroxisome proliferator-activated receptor γ reduces endotoxemic pulmonary inflammation and injury.Pancreatic stellate cells: new kids become mature.Analysis of metabolic characteristics in a rat model of chronic pancreatitis using high-resolution magic-angle spinning nuclear magnetic resonance spectroscopy.Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse.PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.Pancreas transcription factor 1alpha expression is regulated in pancreatitis.PPARγ ligand attenuates portal inflammation in the MRL-lpr mouse: a new strategy to restrain cholangiopathy in primary biliary cirrhosis.COX-2 is not required for the development of murine chronic pancreatitis

P2860

Q21283908-469BA11A-BA36-4580-91CC-1D134CC39100 Q24676727-3CC68B68-E2A9-483C-8772-B809F38E28C2 Q28577532-F65F06DF-5493-4EA1-95F2-35C8CFEA1CDF Q34093784-313220C1-8EAD-4205-A327-2055C760A45C Q34392824-1938F623-6B6D-448D-B43E-89E499FA02E7 Q34565750-6336F0E5-CB6C-4E7F-B50A-8745982ED80D Q34985990-F47218ED-D688-4B6B-8AFF-3653EF3830B7 Q36073919-F6440D69-B834-42C5-8007-12D0D35E77D3 Q36235406-A24AA3E9-A7C7-4D1E-B742-FF7160A091EB Q36898702-73D3AF49-9AA2-42F3-8B8B-80D07D07F19F Q36998028-A5DC112E-E35C-48E1-86CE-FDB4A8F8DB36 Q37021709-0D2B711B-D37F-48D6-B68F-41372BBAFD71 Q37039920-16898F8A-F067-4328-9C91-6E81017DE152 Q37227987-026CC63A-0C45-4FDF-9A16-DD5AF2DF8450 Q37326564-990A336A-0A10-4934-BCB5-ACEDF6E5423F Q37409275-75077E88-7CD1-4232-B712-310073379D9D Q37589374-27399F2A-C8D7-4F95-A4F9-7FAD76D11E51 Q37624480-ABB4013D-55B5-410D-BFE8-8804217274CE Q37635418-D9F09E6B-2433-4077-B196-D2F0D4F7916B Q37761368-70A2E5A2-22E9-4F66-B462-BE446313AC5A Q39179676-8E98691D-06A6-465F-9F83-54734BE012D8 Q39617664-D2B07EE5-2004-4A84-81FD-8392D7F50EE7 Q40071980-16D94B1F-8D03-4BD3-80DB-E9FC7D41870F Q40816924-D3146977-C4CA-40B4-B97C-195ED66861CA Q41600866-D67E3FCB-9BC5-4228-B0E2-87752C604CBB Q42844331-2AE69E67-AA0F-43AB-9D84-9997A2DA7CFE Q43012910-43E520A6-A52B-455A-8071-01110428ACE8 Q43088280-FCB57508-5989-45D5-8E7D-BC50E9CC3550 Q46830543-B79A4E7D-DB81-4FF9-8D81-F5E1DA30EBB7 Q46987589-A90B2D74-2535-4920-B7A6-FACDEFEB0B4A Q51832077-E7C9C2D7-BB77-47EC-BF07-915A6585CABF Q57546918-E1B71101-DAD7-4F67-9059-2B4F6A78BAB5

P2860

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

http://www.wikidata.org/entity/Q35083721

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

@ast

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

@en

type

label

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

@ast

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

@en

prefLabel

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

@ast

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

@en

P1433

Q35083721-31F9A17F-7C79-4288-8995-52AD58A719F4

P1476

Q35083721-A5F1DCFE-F2CC-47C0-80D6-34F9A2244DC6

P2093

Q35083721-15204AD7-8398-4014-8F84-0A0C62FB2072

Q35083721-2941D0C4-E1D7-4462-89CA-1C44877E116D

Q35083721-4C2C07DD-6211-4150-A625-9D704775EF3D

Q35083721-A05C4851-0C16-42D7-B638-FCD98B351C8E

Q35083721-FB83FCFF-0CA8-41C6-A921-1A3A47CDD959

P2860

Q35083721-04B86105-35D9-4FA8-9DC8-FFB8BFD507FF

Q35083721-2F3D8D02-E930-4927-A782-1BF7B4756CB1

Q35083721-33B41B52-EB89-42CA-9ACB-2F9E3D009B71

Q35083721-3761C0CB-E247-463E-BEC5-052161E0D782

Q35083721-3BEA648B-1A7F-45FD-995F-8C0D5A50715C

Q35083721-40EB0610-3777-456D-8052-B017F868EE68

Q35083721-4BBCE3F8-2A49-43A4-A6E5-F70D5DB9A595

Q35083721-4F55537E-F82E-4BAA-8772-C29AAAEB707D

Q35083721-571F161C-5D07-4C24-9B26-721857B69753

Q35083721-6922AD01-8A5C-4756-93DB-41E4E69E6DE2

P304

Q35083721-87E76BAB-D0DA-4BAE-8840-4BF2814CDE19

P31

Q35083721-A49354F7-D7B9-4F69-A529-2E328D9F4B65

P356

Q35083721-FCB5AF84-CE3A-4ADE-B602-95C9EB81BD78

P407

Q35083721-F3519A9D-DB44-4FDC-B9F6-34D5601C9DB6

P433

Q35083721-8EDBDB22-EB5B-4F37-AC35-00B78CFFB53F

P478

Q35083721-2926366A-3AFC-4CF1-94EE-E22DE66C9DA8

P50

Q35083721-5E2DCF5B-389E-47BC-B40D-FB7529355169

Q35083721-EEF8B158-5CA9-4E81-B089-B3F6B4A33191

P577

Q35083721-D7BA30FF-7549-461C-A553-194EC38268D7

P5875

Q35083721-F9116E8D-B694-4C56-A4E5-BE0D10321506

P698

Q35083721-BA218BA3-A53D-48DD-B18E-4DDFF944E462

P932

Q35083721-89C545F3-A0DB-4694-AB2D-12759E916E9A

P356

S0002-9440(10)62293-6

P1433

The American Journal of Pathology

P1476

Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

@en

P2093

Alex F de Vos

http://www.w3.org/2001/XMLSchema#string

Anita M de Boer

http://www.w3.org/2001/XMLSchema#string

David J van Westerloo

http://www.w3.org/2001/XMLSchema#string

Joost Daalhuisen

http://www.w3.org/2001/XMLSchema#string

Marco J Bruno

http://www.w3.org/2001/XMLSchema#string

P2860

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

Immunocytes and activated stellate cells in pancreatic fibrogenesis.

TGFbeta and the extracellular matrix in pancreatitis.

Chronic pancreatitis: diagnosis, classification, and new genetic developments.

Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.

Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.

Inflammatory status and insulin resistance.

Glitazones: clinical effects and molecular mechanisms.

PPAR and immune system--what do we know?

Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.

P304

721-728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)62293-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

Sandrine Florquin

Tom van der Poll

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7989863

http://www.w3.org/2001/XMLSchema#string

P698

15743784

http://www.w3.org/2001/XMLSchema#string

P932

1602356

http://www.w3.org/2001/XMLSchema#string